Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check3 days agoChange DetectedAdded related topic references and a grant/contract note to the study page, indicating indexing and topic associations rather than changes to trial design or eligibility. The additions include a 2016 NIH grant/contract line, and references to Prostate Cancer and MedlinePlus Genetics.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page’s related topics section no longer includes Prostate cancer and MedlinePlus Genetics, removing those cross-reference links from the study record.SummaryDifference0.1%

- Check17 days agoChange DetectedDifference0.1%

- Check32 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This signals a small update to the page's version history rather than changes to the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page no longer displays the Prostate cancer condition label and the related topics/MedlinePlus Genetics section, reducing visible background context and external reference links for the study.SummaryDifference0.1%

- Check53 days agoChange DetectedRelated topics Prostate cancer and MedlinePlus Genetics were added to the page, broadening the topics linked to the study.SummaryDifference0.1%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.